?hydrothorax

hydrothorax 發(fā)音

英：[?ha?dr??θo?r?ks]　　美：[?ha?dr???θ??r?ks]

英：　　美：

hydrothorax 中文意思翻譯

hydrothorax 短語(yǔ)詞組

1、chylous hydrothorax ─── [醫] 乳糜胸

hydrothorax 相似詞語(yǔ)短語(yǔ)

1、hydrothoraces ─── 胸腔積液

2、hydrotherapy ─── n.水治療法

3、hydrotheca ─── n.螅鞘，水螅鞘

4、hydrothermal ─── adj.[地質(zhì)]熱液的；熱水的

5、hydrochoric ─── [植]水播的

6、hydrochores ─── 水道

7、hydrocoral ─── n.水螅珊瑚類(lèi)

8、hydrochore ─── n.[植]水布植物；水播植物

9、hydrothoracic ─── 胸腔積液

hydrothorax 常見(jiàn)例句（雙語(yǔ)使用場(chǎng)景）

1、?Injection of IL-2 with LAK cells (IL?2/LAK) into abdomen or thorax was used to treat ascites or hydrothorax caused by carcinomas in 14 patients and the total efficiency (CR plus PR) was 71?42%. ─── 白細胞介素2（IL－2）聯(lián)合淋巴因子活化的殺傷細胞（LAK細胞）胸腹腔內注入治療癌性胸腹水14例，總有效率71.42%。

2、Methods It was measured the ET,FN and CEA in hydrothorax and serum by radiation immunity,ELISA and immunity radiation method respectively. ─── 方法應用放免法、ELISA、免放法分別檢測胸水及血清中的ET,FN,CEA。

3、Keywords Hydrothorax: The dehydrogenation enzyme of lactic acid;Gerontal; ─── 關(guān)鍵詞胸腔積液;乳酸脫氫酶;老年性;

4、Acute, massive, unilateral hydrothorax is an uncommon but easily recognized complication of continuous ambulatory peritoneal dialysis (CAPD). ─── 摘要急性、大量且單側性水胸是連續性腹膜透析一個(gè)不常見(jiàn)但容易辨別的并發(fā)癥。

5、Keywords Carcinomatous hydrothorax;Heated hypotonic fluid;Thoracic perfusion; ─── 癌性胸水;高溫低滲液;胸腔灌注;

6、Objective To probe the differentiation diagnosis value for combined measuring of serum and hydrotho-rax ET,FN,CEA in benign and malignant hydrothorax. ─── 目的探討胸水及血清ET(內皮素)、FN(纖維連接蛋白)、CEA(癌胚抗原)ET,FN,CEA聯(lián)合檢測對良惡性胸水的鑒別診斷價(jià)值。

7、Tuberculous hydrothorax ─── 結核性胸腔積液

8、Keywords Hydrothorax;hydroperitoneum;Thermochemotherapy;T cell subset;Vascular endothelial growth factor; ─── 惡性胸腹腔積液;熱化療;T細胞亞群;血管內皮生長(cháng)因子;

9、Comparison of results of TCT cytological test and conventional examination in detection of hydrothorax and hydroperitoneum ─── TCT與傳統涂片法作胸腹水細胞學(xué)檢查的對比分析

10、The influence of isolated hydrothorax examined at different time on the exfoliative cytology ─── 離體胸水不同時(shí)間送檢對脫落細胞形態(tài)的影響

11、This article gives a general account of recent years clinical situation of treating lung-cancer-caused cancerous hydrothorax by Chinese, Western and combined Chinese and Western medicines. ─── 作者綜述了近年來(lái)西醫、中醫、中西醫結合治療肺癌癌性胸水的臨床治療狀況。

12、Conclusion The detection of multiple tumor markers in diagnosis of the benign and malignant hydrothorax and ascites was helpful. ─── 結論 檢測胸腹水多腫瘤標志物有助于良惡性胸腹水鑒別診斷。

13、We obtained the hydrothorax specimens and the pleural membrane specimens by puncture. ─── 穿刺取得胸水標本和胸膜標本。

14、In the remaining patients, the perioperative complications included lung infection (7 cases), pulmonary atelectasis (5 cases), hydrothorax (1 case), and pulmonary hypertension crisis (2 cases); ─── 其余患者并發(fā)肺部感染7例，肺不張5例，胸腔積液1例，肺高壓危象2例。

15、Clinical research of malignant hydrothorax or hydroperitoneum treated with intracavitary chemotherapy and local endogenetic thermotherapy ─── 內生場(chǎng)熱療聯(lián)合腔內化療治療惡性胸腹腔積液的臨床研究

16、1 patient with 10(superscript th) subocostal and upper calyx nephrostomy, suffered from light hydrothorax after the nephrostomy tube was pulled out on 6(superscript th) day postoperation. ─── 1例第10肋間上盞穿刺入路患者，術(shù)后第6天拔除腎造瘺管后出現輕度液胸。

17、tuberculous encapsulated hydrothorax ─── 結核性包裹性胸腔積液

18、Objective To evaluate the effect of CCE chemotherapy combined PYM and AT 1258 intrathoracic instillation on lung cancer accompanied hydrothorax. ─── 目的 觀(guān)察CCE化療聯(lián)合胸腔內灌注平陽(yáng)霉素、消瘤芥治療肺癌伴胸腔積液療效。

19、Objective To observe the value of ADA in differential diagnosis of hydrothorax. ─── 目的觀(guān)察胸水ADA對胸腔積液鑒別診斷的價(jià)值。

20、There was significant difference in upper digestive tract hemorrhage(4/11 vs 1/24;P0.05)between these two groups; ─── 二組間在上消化道出血發(fā)生率(4/11 vs 1/24)差異有統計學(xué)意義(P0.05);

21、The diagnosis of hepatic hydrothorax should be suspected in a patient with established cirrhosis and portal hypertension, presenting with a unilateral pleural effusion, most commonly right-sided. ─── 病人患有肝硬化和門(mén)脈高壓癥，很可能會(huì )發(fā)生肝性胸水，最常見(jiàn)的是右側單側胸腔積液。

22、Methods Two cases of fetal disorder (one case of giang fetal urinary bladder and one case of fetal hydrothorax) were treated by fetal thoracentesis, punctio vesicae and treatment after birth. ─── 方法對2例先天疾病胎兒(1例胸腔積液,1例胎兒巨大膀胱)采用超聲波引導下的穿刺治療。

23、Objectier:To study the clinical features,mechanism and treatment of hepatic hydrothorax. ─── 目的:探討肝硬化并發(fā)肝性胸水的臨床表現、發(fā)生機理及治療。

24、TCM Interpretation of Cancerous Hydrothorax Pathogenesis and Its Treatment ─── 癌性胸水的中醫病機認識與治療

25、Results The positive rate of serum and hydrothorax CEA in malignant group were significantly higher than that in benign pleural effusion（P

26、Objective To determine the causes and differential diagnosis of effusion hydrothorax(PEE). ─── 目的探討滲出性胸腔積液(PEE)的病因及鑒別診斷。

27、6. 1 case was combined with stress ulcer with conservation therapy. 1 case had hydrothorax and healed after anti-infection. ─── 1例合并應激性潰瘍,經(jīng)保守治療痊愈,1例發(fā)生胸腔積液,抗感染治療后痊愈;收藏指正

28、After the operation, the patient had no recurrence of hydrothorax and underwent CAPD safely. ─── 術(shù)后，病人無(wú)水胸復委且可安全地進(jìn)行連續性腹膜透析。

29、Keywords Selfheal spike injection Bronchopulmonary carcinoma Hydrothorax Animal experime; ─── 夏枯草注射液;支氣管肺癌;胸水;動(dòng)物實(shí)驗;

30、The efficacy of bronchial artery infusion chemotherapy combined with immunotherapy for lung cancer with malignant hydrothorax ─── 支氣管動(dòng)脈灌注化療加免疫治療肺癌伴惡性胸水的臨床研究

31、Keywords X-ray chest film;Cholesterin;Hydrothorax;Calcification; ─── 線(xiàn)胸片;膽固醇;胸腔積液;鈣化;

32、Methods The clinical data of 69 cases with senile hydrothorax was analyzed retrospectively. ─── 方法對69例老年胸腔積液的臨床資料進(jìn)行回顧性分析。

33、1 case was combined with stress ulcer with conservation therapy. 1 case had hydrothorax and healed after anti-infection. ─── 1例合并應激性潰瘍,經(jīng)保守治療痊愈,1例發(fā)生胸腔積液,抗感染治療后痊愈;

34、Objective to Analyse the age, causes, treatment and recovery of hydrothorax patients. ─── 目的：分析胸腔積液的年齡、病因、治療、轉歸情況。

35、Objective: To analyse the cause of hydrothorax in the process of hemodialysis and treatment. ─── 目的：探討觀(guān)察維持性血液透析患者發(fā)生胸腔積液的病因，并總結治療體會(huì )。

36、Treatment of patients with malignant hydrothorax and ascitic fluid by central venous draining and irrigation of drug ─── 中心靜脈導管引流及注藥治療惡性胸腹水的療效觀(guān)察

37、Clinical Observation on Treatment of Malignant Hydrothorax with Ribonucleic Acid Intrapleural Injection ─── 核糖核酸局部胸腔灌注治療惡性胸水的臨床觀(guān)察

38、Cancerous Hydrothorax ─── 癌性胸水

39、Method Make an analysis on the causes, treatment and recovery of the hydrothorax patients, especially the young group and the quinquagenarian group. ─── 方法:對73例胸腔積液病例特別是青年組和中老年組的病因、治療、轉歸進(jìn)行分析。

40、Methods Thirty cases in treatment group were treated by oral administration of herbs and intrathoracic perfusion of herbal injection after hydrothorax drainage; ─── 方法設治療組30例采用中藥內服，胸水引流后針劑欖香烯腔內灌注；

41、The clinical effect of intrathoracic instillation of chemotherapy combined group A streptococcus injection in 40 patients with lung cancer accompanied severe hydrothorax ─── 化療聯(lián)合胸腔內注射沙培林治療肺癌伴大量胸腔積液40例臨床觀(guān)察

42、transudatory hydrothorax ─── 漏出性胸腔積液

43、In this case, blood filled the pleural cavity (hemothorax), but atelectasis could also result from filling the chest with air (pneumothorax), transudate (hydrothorax), lymph (chylothorax), or purulent exudate (empyema). ─── 但是肺不張也可由胸腔內充滿(mǎn)氣體（氣胸）、漏出液（胸水）、淋巴(乳糜胸)，或者膿性滲出物（膿胸）引起。

44、Artificial Hydrothorax in Aid of Sonographically Guided Local Therapy for Liver Tumors in the Hepatic Dome ─── 人工胸水協(xié)助超聲引導肝穹窿部腫瘤治療

45、After thermochemotherapy,the ratio of CD4/CD8 was increased significantly(P

46、Conclusion The accurate diagnosis was made by detecting mesothelima cell in hydrothorax and hydroperitoneum ... ─── 本病例從胸水及腹水中查見(jiàn)惡性間皮瘤細胞而得以確診。

47、Acute, massive, unilateral hydrothorax is an uncommon but easily recognized complication of continuous ambulatory peritoneal dialysis( CAPD). ─── 摘要急性、量且單側性水胸是連續性腹膜透析一個(gè)不常見(jiàn)但容易辨別的并發(fā)癥。

48、Determination of SIL-2R in Tuberculous and Cancerous Hydrothorax and Its Significance ─── 結核、癌性胸水中可溶性白細胞介素2受體的測定及其意義

49、Keywords Zadaxin;biological and chemical therapeutics;lung cancer with hydrothorax; ─── 關(guān)鍵詞日達仙;生物治療聯(lián)合化療;肺癌并胸腔積液;

50、We herein present a patient with CAPD-related massive hydrothorax who was diagnosed as having a diaphragmatic defect. ─── 在此我們介紹了一位與連續性腹膜透析相關(guān)的大量水胸且診斷為橫膈缺損的病例。

51、513 cells of adenocarcinoma from hydrothorax and ascitic fluid dyed in EMA were measured. The results showed that the sensitivity is 94.2%, the specificity 100% and the accuracy 95.6%. ─── 對513個(gè)EMA染色的胸腹水腺癌細胞進(jìn)行了測試,結果表明該法對EMA染色定量判斷的靈敏度為94.2%,特異度為100%,準確度為95.6%。

52、another 20 cases in control group were treated by intrathoracic perfusion of cisplatin and Mutamycin after hydrothorax drainage, both with a course of one month. ─── 對照組20例，胸水引流后，采用順鉑、絲裂霉素腔內灌注，兩組1個(gè)月后觀(guān)察療效。

53、Keywords Experimental hydrothorax;rabbit model;"Prunella Injection"pleural fibrosis; ─── 實(shí)驗性胸腔積液;家兔模型;夏枯草注射液;胸膜纖維化;

54、Observation of united assay result of CEA in bronchovesicular perfusate, hydrothorax and serum of patients with and without pulmonary cancer ─── 對肺癌及非肺癌患者進(jìn)行支氣管肺泡灌洗液、胸水、血清的癌胚抗原聯(lián)合測定結果的觀(guān)察

55、A right-sided hydrothorax in association with this tumor is known as Meig's syndrome. ─── 此腫瘤伴發(fā)右側胸水被稱(chēng)為Meig氏綜合癥。

56、Main body signs:enlargement of supraclavicular lymph nodes, metastatic carcinoma of bone and hydrothorax. ─── 在鏡下按兩種腫瘤的任何一種必須占全部腫瘤的20%以上的標準診斷。

57、The major manifestations of OHSS included abdominal distension, nausea, ascites, hydrothorax, oliguria, concentrated blood, acid-base and electrolytea,disturbance, azotemia, thrombosis etc. ─── 經(jīng)白蛋白、低分子右旋糖酐、6%賀斯等擴容治療,腹腔、胸腔穿刺放液,甚至終止妊娠等措施治療后痊愈。

58、Exploration of clinical diagnostic value of measuring sulfate glycosaminoglycan segment and antibody to tuberculosis in patients with hydrothorax ─── 硫酸氨基葡糖多聚糖片段與結核抗體檢測對胸腔積液診斷價(jià)值的探討

59、Methods X-ray chest films of 6 patients with cholesterin-contained hydrothorax provn by pleural fluid examination were analyzed retrospectively. ─── 方法回顧性分析經(jīng)檢查胸水證實(shí)為膽固醇性胸腔積液6例患者的X線(xiàn)胸片。

60、Keywords cytology;cytokeraetin 19 fragment;hydrothorax; ─── 關(guān)鍵詞細胞學(xué);細胞角蛋白19片段;胸水;

61、Methods Serum and hydrothorax fluid levels of CEA, CA125, NSE were determined with RIA in 88 patients with lung cancers, 100 patients with inflammatory hydrothorax, and 50 controls. ─── 方法:用放射免疫分析檢測88例肺癌和100例炎性胸腔積液患者血清、胸腔積液以及50例健康對照組人員血清CEA、CA125和NSE含量。

62、Method: Carcinoembryonic Antigen(CEA) and Carbohydrate Antigen(CA153,CA199,CA125) in serum and hydrothorax of both benign and malignant cases were measured. ─── 方法:采用放射免疫分析法,測定良惡性胸水患者的血清和胸水CA153、CA199、CA125、CEA進(jìn)行比較。

63、Malignant hydrothorax ─── 惡性胸水

64、Objective To observe the value of ADA in differential diagnosis of hydrothorax. ─── 目的觀(guān)察胸水ADA對胸腔積液鑒別診斷的價(jià)值。

65、Exploration on the Function of Traditional Routine Examination of Ascites of Hydrothorax Replaced by UF-100 Flow Vrine Analyzer ─── UF-100型流式尿液分析儀代替傳統胸腹水細胞常規檢查的探討

66、Objective:To observe the effect of malignant hydrothorax treatd with Juanyin Decoctionand intrathoracic chemotherapy. ─── 目的觀(guān)察蠲飲湯配合腔內化療治療惡性胸腔積液的臨床療效。

67、Keywords Survivin mRNA;Hydrothorax;Lung cancer; ─── 生成素基因;胸腔積液;肺癌;

68、Objective:To analyse the cause of hydrothorax in the process of hemodialysis and treatment. ─── 目的:探討觀(guān)察維持性血液透析患者發(fā)生胸腔積液的病因,并總結治療體會(huì )。

69、Methods We detected ADA pleural fluid in 188 patients with pleural effusion.The patients were divided into three groups of malignant hydrothorax, tuberculous hydrothorax and transudative hydrothorax. ─── 方法測定本院188例胸腔積液病人的胸水ADA,分別按惡性胸腔積液、結核性胸腔積液、漏出性胸腔積液三組比較。

70、Hydragogue diuretic repercusion capsules and Haibaidonghe soup's therapy observation on 22 patients with malignant hydrothorax ─── 利水消腫膠囊與海白冬合湯治療惡性胸水22例近期療效觀(guān)察

71、Keywords C-reactive protein;Adenosine deaminase;Senile hydrothorax; ─── 關(guān)鍵詞C反應蛋白;腺苷脫氨酶;胸腔積液;老年人;

72、Was it really hepatic hydrothorax? ─── 肝性胸水是真的嗎？

73、Malignancy hydrothorax ─── 惡性胸腔積液

74、Keywords tuberculous pleuritis;hydrothorax;encysted pleuritis tubercle; ─── 結核性胸膜炎;胸腔積液;包裹性胸膜炎;

75、The operative diseases include sponlanevus pneumothorax, pulmonary bulla, trauma hemothorax, empyema, pernicious hydrothorax, mediastina tumor, esophageal diseases and lung diseases, etc. ─── 手術(shù)疾病包括自發(fā)性氣胸、肺大皰、外傷性血胸、膿胸、惡性胸水、縱隔腫瘤、食管和肺疾病等。

76、Clinical Analysis of Combinative Treatment of IL-2 and LAK cells to Ascites and Hydrothorax Caused by Carcinomas ─── IL-2聯(lián)合LAK細胞治療癌性胸腹水臨床分析

77、Objective: To explore the diagnostic significance and application value of determination of hydrothorax ADA for tuberculous pleurisy. ─── 目的：探討胸水腺苷脫氨酶測定對結核性胸膜炎的診斷意義和應用價(jià)值。

78、Methods Clinical data of 207 cases with effusion hydrothorax were retrospectively analyzed according to groups of different ages. ─── 方法回顧性分析了207例胸腔積液患者各年齡組的臨床表現資料。

79、Observention and nursing of therapy patients with malignant hydrothorax and ascetic fluid by central venous draining ─── 應用中心靜脈導管引流惡性胸腹水的觀(guān)察與護理

80、Methods: 74 patients with severe hydrothorax of cancer cure in our department were observed.The clinical effects of streptococcus and cisplatin on these patients were evaluated. ─── 方法將收治的74例患者隨機分為三組:治療組采用沙培林加順鉑治療,對照組分別單用順鉑治療或單用沙培林治療。

81、Application of immunocytochemistry to cytological diagnosis in hydrothorax and ascites ─── 免疫細胞化學(xué)技術(shù)在胸腹水脫落細胞學(xué)診斷中的應用

82、Objective To observe the clinical efficacy of "Fuzhen Tuodu Xiefei Zhuyin Decoction" in the treatment of malignant hydrothorax. ─── 摘要目的觀(guān)察扶正托毒、瀉肺逐飲配合腔內灌注治療對惡性胸腔積液的治療效果。

83、Objective to Analyse the age, causes, treatment and recovery of hydrothorax patients. ─── 目的:分析胸腔積液的年齡、病因、治療、轉歸情況。

84、It was initially used for treating recurrent spontaneous pneumothorax, and then extended to treatment of refractory pneumothorax, malignant pleural effusion and benign hydrothorax. ─── 目前的趨勢是胸內科逐漸以纖支鏡替代胸腔鏡，所用藥物以四環(huán)素或滑石粉為主，治療范圍從氣胸擴展到胸水，氣胸從復發(fā)性擴展到難治性，胸水從惡性擴展到良性。

85、Objective: To assess the diagnostic value of immunocytochemistry in exfoliated cell of hydrothorax and ascites. ─── 摘要目的：探討免疫細胞化學(xué)技術(shù)在胸腹水脫落細胞學(xué)診斷中的應用及其臨床意義。

86、The Analysis of 98 Cases Of Encysted Hydrothorax Developed from Tubercular Hydrothorax ─── 結核性胸腔積液形成纖維包裹性積液98例分析

87、chylous hydrothorax ─── [醫] 乳糜胸

88、In the vast majority of cases, patients with hepatic hydrothorax have end-stage liver disease. ─── 在絕大多數情況下，終末期肝病病人有肝性胸水。